Berry Genomics Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	301.59	379.51	383.07	338.15	333.56	417.89
Trading Asset Securities	2.82	2.82	17.03	13.86	4.51	3.82
Cash & Short-Term Investments	304.41	382.33	400.1	352.01	338.07	421.7
Cash Growth	-15.93%	-4.44%	13.66%	4.12%	-19.83%	-33.39%
Accounts Receivable	559.74	549.34	695.17	815.21	1,063	1,109
Other Receivables	50.14	56.05	76.45	4.97	14.51	34.07
Receivables	609.88	605.38	771.62	820.18	1,077	1,143
Inventory	178.03	176.76	194.91	229.3	230.95	233.88
Prepaid Expenses	-	0.08	0.01	0.14	0.21	1.88
Other Current Assets	84.66	79.52	72.45	71.37	80.15	105.88
Total Current Assets	1,177	1,244	1,439	1,473	1,727	1,907
Property, Plant & Equipment	513.08	519.91	459.07	923.42	1,101	1,131
Long-Term Investments	194.24	187.75	177.19	48.45	138.26	279.07
Goodwill	13.43	13.43	13.43	13.43	13.43	13.43
Other Intangible Assets	64.3	66.4	31.68	49.67	51.6	52.21
Long-Term Accounts Receivable	-	-	0.31	-	-	-
Long-Term Deferred Tax Assets	150.44	150.42	144.07	151.27	104.8	63.93
Long-Term Deferred Charges	103.28	102.24	89.77	48.44	41.04	46.71
Other Long-Term Assets	-	-	30.11	33.49	26.66	27.05
Total Assets	2,216	2,284	2,385	2,741	3,203	3,520
Accounts Payable	211.38	272.91	287.51	292.48	278.9	339.93
Accrued Expenses	45.5	52.41	55.81	64.95	63.14	66.16
Short-Term Debt	155.08	154.32	113.42	202.64	203.69	190.54
Current Portion of Long-Term Debt	-	-	-	42.3	-	-
Current Portion of Leases	-	11.55	3.63	12.95	13	9.44
Current Income Taxes Payable	-	2.91	3.9	11.91	0.38	13.44
Current Unearned Revenue	120.8	119.66	103.49	110.75	103.56	90.55
Other Current Liabilities	26.78	22.24	22.81	25.11	42.05	58.52
Total Current Liabilities	559.55	635.99	590.56	763.09	704.72	768.58
Long-Term Debt	-	-	-	42.18	126.6	185.7
Long-Term Leases	108.43	107.29	43.24	3.5	4.88	13.62
Long-Term Unearned Revenue	11.03	10.94	10.87	11.02	12.07	3.66
Long-Term Deferred Tax Liabilities	25.97	25.92	24.9	26.77	25.89	24.46
Total Liabilities	704.97	780.14	669.56	846.56	874.17	996.02
Common Stock	353.52	353.52	353.52	353.52	354.61	354.61
Additional Paid-In Capital	1,163	1,163	1,159	1,156	1,211	1,160
Retained Earnings	-76.06	-56.32	145.39	337.82	765.02	1,020
Treasury Stock	-	-	-	-	-44.52	-44.52
Comprehensive Income & Other	12.92	16.41	21.1	16.5	15.39	0.63
Total Common Equity	1,453	1,476	1,679	1,864	2,301	2,490
Minority Interest	57.76	27.85	35.69	30.57	27.94	33.51
Shareholders' Equity	1,511	1,504	1,715	1,895	2,329	2,524
Total Liabilities & Equity	2,216	2,284	2,385	2,741	3,203	3,520
Total Debt	263.51	273.15	160.28	303.58	348.17	399.3
Net Cash (Debt)	40.9	109.18	239.82	48.43	-10.11	22.4
Net Cash Growth	-58.41%	-54.47%	395.21%	-	-	-91.81%
Net Cash Per Share	0.12	0.31	0.68	0.14	-0.03	0.06
Filing Date Shares Outstanding	328.97	353.52	353.52	353.52	353.52	353.52
Total Common Shares Outstanding	328.97	353.52	353.52	353.52	353.52	353.52
Working Capital	617.44	608.09	848.53	709.9	1,022	1,138
Book Value Per Share	4.42	4.18	4.75	5.27	6.51	7.04
Tangible Book Value	1,375	1,396	1,634	1,801	2,236	2,425
Tangible Book Value Per Share	4.18	3.95	4.62	5.09	6.33	6.86
Buildings	-	317.47	317.47	606.22	684.23	684.08
Machinery	-	647.34	623.32	638.82	591.45	553.45
Construction In Progress	-	9.51	-	230.8	290.95	267.6